Read this company snapshot
Daily valuation snapshot
Pulmonx Corporation Common Stock: source evidence dated 2026-10-09.
- Daily close (USD)
- $1.84
- Market capitalization (USD)
- $79,024,814.96
- Price / earnings (TTM)
- Not reported
- Price / book
- 2.02
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research LUNG in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research LUNG in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing LUNG with another company.
| Daily close (USD) | $1.84 |
| Market capitalization (USD) | $79,024,814.96 |
| Price / earnings (TTM) | Not reported |
| Price / book | 2.02 |
No matching rows. Clear the filter to see all records.
Read LUNG's valuation metrics
Company size
Pulmonx Corporation Common Stock's recorded market capitalization is $79,024,814.96. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
LUNG's recorded price-to-book ratio is 2.02. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Pulmonx Corporation Common Stock with Aurora
Use the snapshot above to ask a specific question about LUNG. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow LUNG's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.